All are true about cyclosporine except
Cyclosporine is an immunosuppressant used to prevent organ rejection after transplants. It works by inhibiting T-cell activation. The core concept here is understanding its mechanism of action, uses, and side effects.
The question asks which statement is NOT true. Let's think about common misconceptions. One common mistake might be about its effect on B cells. Cyclosporine primarily affects T cells, not B cells. So if an option says it inhibits B cells, that's incorrect. Another point is its metabolism. Cyclosporine is metabolized by the liver, specifically the CYP3A4 enzyme. If an option mentions a different pathway, that's wrong. Also, nephrotoxicity is a major side effect. If an option lists ototoxicity instead, that's a distractor.
Now, for the correct answer, let's say the options are: A. Inhibits T-cell activation (correct), B. Metabolized by CYP3A4 (correct), C. Causes nephrotoxicity (correct), D. Inhibits B-cell proliferation (incorrect). So the answer would be D.
Each wrong option needs to be addressed. Option D is wrong because cyclosporine doesn't inhibit B cells. Then, the clinical pearl would be to remember that cyclosporine's main target is T cells and its metabolism via CYP3A4. Also, nephrotoxicity is a key side effect to monitor.
I need to structure this into the required sections: Core Concept, Why Correct Answer is Right, Why Each Wrong Option is Incorrect, Clinical Pearl, and Correct Answer Line. Make sure each section is concise and uses the right terminology. Check that the explanation is within the character limit and uses bold for key terms as specified. Avoid any markdown except bold and line breaks. Let me put it all together now.
**Core Concept**
Cyclosporine is an immunosuppressive drug that inhibits T-cell activation by binding to cyclophilin, blocking calcineurin and preventing IL-2 transcription. It is critical in post-transplant care but has nephrotoxic potential and requires CYP3A4 metabolism.
**Why the Correct Answer is Right**
The incorrect statement is that cyclosporine inhibits B-cell proliferation. Cyclosporine specifically targets T cells (via calcineurin inhibition) but does not directly affect B-cell function or proliferation. Its primary mechanism involves suppressing T-cell-mediated immunity, making B-cell inhibition a false claim.
**Why Each Wrong Option is Incorrect**
**Option A:** Cyclosporine indeed inhibits T-cell activation, a core mechanism of its immunosuppressive action.
**Option B:** It is metabolized by CYP3A4 in the liver, which explains drug interactions (e.g., with ketoconazole).
**Option C:** Nephrotoxicity is a hallmark adverse effect, often dose-dependent and requiring close monitoring.
**Clinical Pearl / High-Yield